Essex Savings Bank Raises Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Essex Savings Bank lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,888 shares of the exchange traded fund’s stock after purchasing an additional 500 shares during the quarter. Essex Savings Bank’s holdings in SPDR S&P Biotech ETF were worth $234,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of XBI. Van ECK Associates Corp purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth $1,497,000. Vontobel Holding Ltd. raised its holdings in SPDR S&P Biotech ETF by 5.4% in the 4th quarter. Vontobel Holding Ltd. now owns 6,893 shares of the exchange traded fund’s stock worth $621,000 after purchasing an additional 351 shares during the period. Bank Pictet & Cie Europe AG lifted its position in SPDR S&P Biotech ETF by 28.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 9,110 shares of the exchange traded fund’s stock valued at $820,000 after purchasing an additional 2,040 shares in the last quarter. Principal Securities Inc. grew its holdings in SPDR S&P Biotech ETF by 37.9% during the fourth quarter. Principal Securities Inc. now owns 12,106 shares of the exchange traded fund’s stock valued at $1,090,000 after purchasing an additional 3,325 shares during the period. Finally, Truist Financial Corp grew its holdings in SPDR S&P Biotech ETF by 28.5% during the fourth quarter. Truist Financial Corp now owns 43,900 shares of the exchange traded fund’s stock valued at $3,954,000 after purchasing an additional 9,746 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.7%

NYSEARCA XBI opened at $82.66 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $105.47. The company has a market capitalization of $4.90 billion, a P/E ratio of 11.47 and a beta of 0.85. The stock’s 50-day moving average price is $79.83 and its 200-day moving average price is $85.94.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.